Lithium Treatment to Prevent Cognitive Impairment After Brain Radiotherapy

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
Randomized, placebo-controlled, double-blinded, parallel group clinical trial to investigate if 6 months of oral lithium tablets (S-lithium 0,5-1,0 mmol/l) will prevent cognitive decline after brain radiotherapy in pediatric brain tumor survivors. Primary outcome measure is Processing Speed Index (PSI) 2 years after start of study treatment.
Epistemonikos ID: 13939fe8ac5d9c19834c99b686a1b64a3c5b6106
First added on: May 15, 2024